Clinical Trial Update: Efficacy and Safety of XT-150 in Osteoarthritis of the Knee [Phase 2]

View source ↗

Summary

Phase 2 trial results update for XT-150 in knee osteoarthritis, reporting efficacy and safety outcomes. The study status is completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• XT-150

Snippet

Sponsor: Xalud Therapeutics, Inc. | Conditions: Osteoarthritis, Knee | Phase 2 | Status: COMPLETED | Results posted: 2025-03-27